BioMarin Pharmaceutical Inc.

XTRA:BM8 Rapport sur les actions

Capitalisation boursière : €15.4b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

BioMarin Pharmaceutical Croissance future

Future contrôle des critères 4/6

BioMarin Pharmaceutical is forecast to grow earnings and revenue by 34% and 12.9% per annum respectively. EPS is expected to grow by 33.3% per annum. Return on equity is forecast to be 14.3% in 3 years.

Informations clés

34.0%

Taux de croissance des bénéfices

33.3%

Taux de croissance du BPA

Biotechs croissance des bénéfices35.4%
Taux de croissance des recettes12.9%
Rendement futur des capitaux propres14.3%
Couverture par les analystes

Good

Dernière mise à jour20 Feb 2024

Mises à jour récentes de la croissance future

Recent updates

Prévisions de croissance des bénéfices et des revenus

XTRA:BM8 - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20263,6937411,0291,30016
12/31/20253,28055882596924
12/31/20242,82334554466527
12/31/20232,40819040036427
9/30/20232,31114731139N/A
6/30/20232,23510041161N/A
3/31/20232,1737222147N/A
12/31/20222,09614244176N/A
9/30/20222,0088441180N/A
6/30/20221,91254-4119N/A
3/31/20221,8803924146N/A
12/31/20211,846-64185305N/A
9/30/20211,84916165280N/A
6/30/20211,917837155269N/A
3/31/20211,84479592214N/A
12/31/20201,860854-5285N/A
9/30/20201,86385275156N/A
6/30/20201,84712258140N/A
3/31/20201,805114388N/A
12/31/20191,704-24-9048N/A
9/30/20191,603-43-5940N/A
6/30/20191,533-110-11217N/A
3/31/20191,519-90-878N/A
12/31/20181,491-77-7420N/A
9/30/20181,496-125-12-15N/A
6/30/20181,439-125-14-23N/A
3/31/20181,383-145-629N/A
12/31/20171,314-117-83-9N/A
9/30/20171,255-156-234-24N/A
6/30/20171,201-181N/A-72N/A
3/31/20171,184-563N/A-137N/A
12/31/20161,117-630N/A-228N/A
9/30/20161,045-471N/A-293N/A
6/30/2016974-524N/A-286N/A
3/31/2016924-187N/A-253N/A
12/31/2015890-172N/A-219N/A
9/30/2015892-310N/A-179N/A
6/30/2015859-212N/A-185N/A
3/31/2015801-163N/A-183N/A
12/31/2014749-134N/A-70N/A
9/30/2014666-126N/A-58N/A
6/30/2014627-187N/A-59N/A
3/31/2014572-175N/A-54N/A
12/31/2013548-176N/A-57N/A
9/30/2013534-167N/A-36N/A
6/30/2013525-120N/A-13N/A
3/31/2013512-130N/A-7N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: BM8's forecast earnings growth (34% per year) is above the savings rate (0.6%).

Bénéfices vs marché: BM8's earnings (34% per year) are forecast to grow faster than the German market (13% per year).

Croissance élevée des bénéfices: BM8's earnings are expected to grow significantly over the next 3 years.

Chiffre d'affaires vs marché: BM8's revenue (12.9% per year) is forecast to grow faster than the German market (4.8% per year).

Croissance élevée des revenus: BM8's revenue (12.9% per year) is forecast to grow slower than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: BM8's Return on Equity is forecast to be low in 3 years time (14.3%).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y